Reivindicaciones

1. A compound of formula: <img class="EMIRef" id="460046602-ib0037" /> <img class="EMIRef" id="460046602-ib0038" /> <img class="EMIRef" id="460046602-ib0039" /> <img class="EMIRef" id="460046602-ib0040" /> <img class="EMIRef" id="460046602-ib0041" /> <img class="EMIRef" id="460046602-ib0042" /> <img class="EMIRef" id="460046602-ib0043" /> <img class="EMIRef" id="460046602-ib0044" /> <img class="EMIRef" id="460046602-ib0045" /> <img class="EMIRef" id="460046602-ib0046" /> <img class="EMIRef" id="460046602-ib0047" /> <img class="EMIRef" id="460046602-ib0048" /> <img class="EMIRef" id="460046602-ib0049" /> <img class="EMIRef" id="460046602-ib0050" /> <img class="EMIRef" id="460046602-ib0051" /> <img class="EMIRef" id="460046602-ib0052" /> <img class="EMIRef" id="460046602-ib0053" /> <img class="EMIRef" id="460046602-ib0054" /> <img class="EMIRef" id="460046602-ib0055" /> <img class="EMIRef" id="460046602-ib0056" /> <img class="EMIRef" id="460046602-ib0057" /> <img class="EMIRef" id="460046602-ib0058" /> <img class="EMIRef" id="460046602-ib0059" /> or <img class="EMIRef" id="460046602-ib0060" /> 2. A compound according to claim 1 of formula (27): <img class="EMIRef" id="460046602-ib0061" /> 3. A compound according to claim 1 of formula (30): <img class="EMIRef" id="460046602-ib0062" /> 4. A compound according to claim 1 of formula (31): <img class="EMIRef" id="460046602-ib0063" /> 5. A compound according to claim 1 of formula (33): <img class="EMIRef" id="460046602-ib0064" /> 6. A compound according to claim 1 of formula: <img class="EMIRef" id="460046602-ib0065" /> 7. A compound according to claim 1 of formula (2): <img class="EMIRef" id="460046602-ib0066" /> 8. A compound according to claim 1 of formula (5): <img class="EMIRef" id="460046602-ib0067" /> 9. A compound according to claim 1 of formula (6): <img class="EMIRef" id="460046602-ib0068" /> 10. A compound according to claim 1 of formula (8): <img class="EMIRef" id="460046602-ib0069" /> 11. A pharmaceutical composition which contains a compound according to any preceding claim together with a pharmaceutically acceptable diluent. 12. The use of a compound according to any of claims 1 to 10 in the preparation of a medicament for treatment of cancer.